HEADER TRANSFERASE 11-JUN-03 1PMN TITLE CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: STRESS-ACTIVATED PROTEIN KINASE JNK3, C-JUN N-TERMINAL COMPND 5 KINASE 3, MAP KINASE P49 3F12; COMPND 6 EC: 2.7.1.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MK10_HUMAN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BLD21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS MAP KINASE, APOPTOSIS, INHIBITION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.SCAPIN,S.B.PATEL,J.LISNOCK,J.W.BECKER,P.V.LOGRASSO REVDAT 4 16-AUG-23 1PMN 1 REMARK SEQADV REVDAT 3 11-OCT-17 1PMN 1 REMARK REVDAT 2 24-FEB-09 1PMN 1 VERSN REVDAT 1 09-SEP-03 1PMN 0 JRNL AUTH G.SCAPIN,S.B.PATEL,J.LISNOCK,J.W.BECKER,P.V.LOGRASSO JRNL TITL THE STRUCTURE OF JNK3 IN COMPLEX WITH SMALL MOLECULE JRNL TITL 2 INHIBITORS: STRUCTURAL BASIS FOR POTENCY AND SELECTIVITY JRNL REF CHEM.BIOL. V. 10 705 2003 JRNL REFN ISSN 1074-5521 JRNL PMID 12954329 JRNL DOI 10.1016/S1074-5521(03)00159-5 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 21024 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1037 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 21296 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1957 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 114 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2774 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 197 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -16.30000 REMARK 3 B22 (A**2) : 7.07000 REMARK 3 B33 (A**2) : 9.26000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.34 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.470 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.300 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.200 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.900 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MASK REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 52.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PMN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-03. REMARK 100 THE DEPOSITION ID IS D_1000019429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21026 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 22.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.19700 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 1JNK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MME 550, ETHYLENE GLYCOL, HEPES, REMARK 280 PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.53750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.58700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.67050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.58700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.53750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.67050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 38 REMARK 465 ALA A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 ARG A 212 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 PRO A 372 REMARK 465 PRO A 373 REMARK 465 GLN A 374 REMARK 465 ILE A 375 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 LYS A 378 REMARK 465 SER A 401 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 285 CG CD OE1 OE2 REMARK 470 PRO A 371 CG CD REMARK 470 GLN A 379 CG CD OE1 NE2 REMARK 470 GLU A 382 CG CD OE1 OE2 REMARK 470 ARG A 383 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 97 62.47 36.17 REMARK 500 GLN A 140 -48.85 -137.75 REMARK 500 ARG A 188 -6.55 73.62 REMARK 500 PRO A 264 -169.85 -69.28 REMARK 500 PRO A 314 161.03 -48.35 REMARK 500 ALA A 320 47.43 -107.10 REMARK 500 TYR A 363 141.08 -38.50 REMARK 500 ASP A 364 113.71 -160.41 REMARK 500 ALA A 370 -45.12 -156.79 REMARK 500 LEU A 380 122.51 -12.44 REMARK 500 GLU A 382 -78.25 -146.13 REMARK 500 ARG A 383 -178.75 -34.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 984 A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PMQ RELATED DB: PDB REMARK 900 JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1PMU RELATED DB: PDB REMARK 900 JNK3 IN COMPLEX WITH A PHENANTROLINE INHIBITOR REMARK 900 RELATED ID: 1PMV RELATED DB: PDB REMARK 900 JNK3 IN COMPLEX WITH A DIHYDROANTHRAPYRAZOLE INHIBITOR DBREF 1PMN A 40 401 UNP P53779 MK10_HUMAN 40 401 SEQADV 1PMN MET A 38 UNP P53779 CLONING ARTIFACT SEQADV 1PMN ALA A 39 UNP P53779 CLONING ARTIFACT SEQRES 1 A 364 MET ALA SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER SEQRES 2 A 364 VAL GLU VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG SEQRES 3 A 364 TYR GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY SEQRES 4 A 364 ILE VAL CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN SEQRES 5 A 364 VAL ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN SEQRES 6 A 364 THR HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET SEQRES 7 A 364 LYS CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN SEQRES 8 A 364 VAL PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP SEQRES 9 A 364 VAL TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS SEQRES 10 A 364 GLN VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER SEQRES 11 A 364 TYR LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU SEQRES 12 A 364 HIS SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER SEQRES 13 A 364 ASN ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU SEQRES 14 A 364 ASP PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET SEQRES 15 A 364 MET THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO SEQRES 16 A 364 GLU VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP SEQRES 17 A 364 ILE TRP SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG SEQRES 18 A 364 HIS LYS ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN SEQRES 19 A 364 TRP ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO SEQRES 20 A 364 GLU PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR SEQRES 21 A 364 VAL GLU ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO SEQRES 22 A 364 LYS LEU PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU SEQRES 23 A 364 HIS ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SEQRES 24 A 364 SER LYS MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER SEQRES 25 A 364 VAL ASP ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP SEQRES 26 A 364 TYR ASP PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE SEQRES 27 A 364 TYR ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU SEQRES 28 A 364 GLU TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER HET 984 A 501 33 HETNAM 984 CYCLOPROPYL-{4-[5-(3,4-DICHLOROPHENYL)-2-[(1-METHYL)- HETNAM 2 984 PIPERIDIN]-4-YL-3-PROPYL-3H-IMIDAZOL-4-YL]-PYRIMIDIN- HETNAM 3 984 2-YL}AMINE FORMUL 2 984 C25 H30 CL2 N6 FORMUL 3 HOH *197(H2 O) HELIX 1 1 ASN A 101 VAL A 118 1 18 HELIX 2 2 LEU A 153 GLN A 158 1 6 HELIX 3 3 ASP A 162 ALA A 183 1 22 HELIX 4 4 LYS A 191 SER A 193 5 3 HELIX 5 5 ALA A 231 LEU A 236 1 6 HELIX 6 6 ASN A 243 HIS A 259 1 17 HELIX 7 7 ASP A 267 GLY A 280 1 14 HELIX 8 8 CYS A 283 LYS A 289 1 7 HELIX 9 9 GLN A 291 ASN A 300 1 10 HELIX 10 10 THR A 308 PHE A 313 1 6 HELIX 11 11 PRO A 314 PHE A 318 5 5 HELIX 12 12 SER A 322 LEU A 340 1 19 HELIX 13 13 SER A 349 LEU A 354 1 6 HELIX 14 14 HIS A 356 VAL A 361 1 6 HELIX 15 15 ASP A 364 GLU A 369 1 6 HELIX 16 16 THR A 386 ASN A 400 1 15 SHEET 1 A 2 PHE A 48 VAL A 53 0 SHEET 2 A 2 SER A 56 LEU A 61 -1 O SER A 56 N VAL A 53 SHEET 1 B 5 TYR A 64 SER A 72 0 SHEET 2 B 5 ILE A 77 ASP A 83 -1 O VAL A 78 N GLY A 71 SHEET 3 B 5 ARG A 88 SER A 96 -1 O VAL A 90 N ALA A 81 SHEET 4 B 5 ASP A 141 GLU A 147 -1 O VAL A 142 N LEU A 95 SHEET 5 B 5 ASN A 128 PHE A 130 -1 N PHE A 130 O TYR A 143 SHEET 1 C 3 ALA A 151 ASN A 152 0 SHEET 2 C 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 C 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 SITE 1 AC1 16 ILE A 70 SER A 72 VAL A 78 ALA A 91 SITE 2 AC1 16 ILE A 92 LYS A 93 ILE A 124 LEU A 126 SITE 3 AC1 16 LEU A 144 MET A 146 MET A 149 ASP A 150 SITE 4 AC1 16 ALA A 151 SER A 193 ASN A 194 HOH A 673 CRYST1 53.075 71.341 107.174 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018841 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014017 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009331 0.00000